Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

New clot buster comparable to t-PA in AMI

March 18, 1997

Pharmacodynamic effects of xemilofiban in cirrhotics

March 18, 1997

Taisho claims orally active antiplatelet agents

March 18, 1997

NM-702 enters phase II trials

March 14, 1997

Boehringer Mannheim reports new antiplatelet agents

March 13, 1997

Agrylin granted priority review in Canada

March 7, 1997

Thrombin inhibitors disclosed by Astra

March 6, 1997

FDA advisory committee decision regarding Integrilin

March 4, 1997

Fibrinogen antagonists disclosed by Terumo

March 3, 1997

Abciximab and acute profound thrombocytopenia

Feb. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...